Welcome to our dedicated page for Verano Holdings SEC filings (Ticker: VRNOD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Verano Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Verano Holdings's regulatory disclosures and financial reporting.
Verano Holdings Corp., a vertically integrated U.S. cannabis operator active in 13 states, reported Q2 2026 revenues of $217.9 million, up from $202.3 million a year earlier. Gross profit declined to $99.7 million from $113.0 million as cost of goods sold increased. Income from operations fell to $3.1 million and the net loss attributable to the company was $13.4 million (basic and diluted loss per share $0.18), versus a $19.2 million loss in Q2 2025.
For the first six months of 2026, revenue was $426.1 million compared with $412.1 million in 2025, with a net loss of $31.2 million. Operating cash flow improved sharply to $49.2 million from $12.7 million, supporting capex of $26.8 million. Cash and cash equivalents were $85.2 million and total assets $1.70 billion. Debt totaled $392.6 million, including a new $195.0 million senior secured term loan under the 2026 Credit Agreement and $100.0 million drawn on a real-estate backed revolver. Stockholders’ equity was $676.5 million, while uncertain tax positions stood at $400.7 million, contributing to highly unusual effective tax rates influenced by U.S. tax code Section 280E and evolving cannabis rescheduling.
On June 11, 2026 Verano effected a 1‑for‑5 reverse stock split, reducing issued common shares to 73.5 million and authorized common shares to 1.0 billion, with all per‑share data retroactively adjusted. A new repurchase program authorizes buybacks of up to 5% of outstanding common stock or $20 million; during Q2, Verano repurchased 320,000 shares for $2.0 million. Assets held for sale totaled $23.9 million, primarily cultivation and retail facilities, and the company recorded a $4.1 million impairment on a Massachusetts cultivation asset as fair value declined.
Verano Holdings Corp. reported second quarter 2026 results with revenues, net of discounts, of $218 million, up 5% versus the prior quarter and 8% year-over-year. Gross profit was $100 million, a 46% margin, and income from operations was $3.1 million.
The company recorded a net loss attributable to Verano of $13 million, a 6% net loss margin, while Adjusted EBITDA was $51 million, or 24% of revenue. Net cash provided by operating activities was $31 million and capital expenditures were $12 million in the quarter.
As of June 30, 2026, Verano reported current assets of $404 million, including cash and cash equivalents of $85 million, working capital of $295 million, and total debt, net of issuance costs, of $393 million. The company authorized a $20 million stock repurchase program, repurchased $2 million of stock, completed a 1-for-5 reverse stock split, and operated 163 dispensaries across 13 states.
Verano Holdings Corp. registers up to $1,000,000,000 of Common Stock, Warrants, Rights and Units under a shelf prospectus dated July 8, 2026. The shelf permits one or more offerings of any combination of the listed securities, to be sold from time to time with prospectus supplements.
The prospectus notes Verano’s U.S. operations across 13 states, including 162 retail dispensaries and 14 cultivation and processing facilities with over 1.1 million square feet of cultivation capacity. The filing describes uses of proceeds as general corporate purposes and incorporates prior Form 10-K and recent 8-Ks by reference.
Verano Holdings Corp. — This Schedule 13G/A (Amendment No. 3) states that Eminence Capital, LP and Ricky C. Sandler report shared advisory relationships to certain funds and a separately managed account holding Class A Subordinate Voting Shares of Verano Holdings Corp. The cover data incorporated by reference shows 0% beneficial ownership and zero sole/shared voting and dispositive power attributed to the Reporting Persons. The filing clarifies corporate and business addresses and notes that the statement is not an admission of beneficial ownership under Section 13G.
Verano Holdings Corp. reported that its Board of Directors approved updates to its Code of Business Conduct and Ethics on June 20, 2026. The revisions align the Code with other corporate governance documents, better reflect the company’s Nevada domicile, and refresh language on corporate opportunities, competition and fair dealing, confidentiality, and protection and proper use of company assets.
The company states that the underlying ethical principles remain substantively unchanged and that no waivers for any officer, director, or employee result from these updates. The full revised Code is filed as Exhibit 14.1 and will also be available on the company’s investor website.